US 8937093
Heterocyclic aspartyl protease inhibitors
granted A61KA61K31/4168A61K31/4178
Quick answer
US patent 8937093 (Heterocyclic aspartyl protease inhibitors) held by Pharmacopeia Drug Discovery, Inc. expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Pharmacopeia Drug Discovery, Inc.
- Grant date
- Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/4168, A61K31/4178, A61K31/4184, A61K31/4439